PMA N18286S018

Device
GELFOAM PLUS HEMOSTASIS KIT
Applicant
Pfizer, Inc.
PMA number
N18286
Supplement
S018
Product code
LMF
Decision date
2009-06-10
Classification
Agent, Absorbable Hemostatic, Collagen Based
Generic name
Agent, absorbable hemostatic, collagen based
Approval order statement
APPROVAL OF CHANGES TO THE MANUFACTURING OF THE HUMAN THROMBIN COMPONENT OF THE GELFOAM PLUS HEMOSTASIS KIT THROUGH THE ADDITION OF A SOLVENT/ DETERGENT STEP (HUMAN THROMBIN VH S/D). THE THROMBIN IS TO BE MANUFACTURED AND SUPPLIED BY BAXTER HEALTHCARE CORPORATION.

Current openFDA PMA Record#

Device
GELFOAM PLUS HEMOSTASIS KIT
Applicant
Pfizer, Inc.
PMA number
N18286
Supplement
S018
Product code
LMF
Generic name
Agent, absorbable hemostatic, collagen based
Decision date
2009-06-10
Decision code
APPR
Date received
2009-02-26
Supplement type
Normal 180 Day Track
Supplement reason
Change Design/Components/Specifications/Material
Approval order statement
APPROVAL OF CHANGES TO THE MANUFACTURING OF THE HUMAN THROMBIN COMPONENT OF THE GELFOAM PLUS HEMOSTASIS KIT THROUGH THE ADDITION OF A SOLVENT/ DETERGENT STEP (HUMAN THROMBIN VH S/D). THE THROMBIN IS TO BE MANUFACTURED AND SUPPLIED BY BAXTER HEALTHCARE CORPORATION.